BARINTHUS BIOTHERAPEUTICS PLC Income (Loss) from Continuing Operations before Income Taxes, Domestic
BARINTHUS BIOTHERAPEUTICS PLC (BRNS) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$42.54 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-13
- BARINTHUS BIOTHERAPEUTICS PLC income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$42.54M.
- BARINTHUS BIOTHERAPEUTICS PLC income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$27.51M.
- BARINTHUS BIOTHERAPEUTICS PLC income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$50.53M, a 425.79% decline from fiscal 2022.
- BARINTHUS BIOTHERAPEUTICS PLC income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was $15.51M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$42.54M 10-K · filed 2026-03-13 |
| 2024-12-31 | -$27.51M 10-K · filed 2026-03-13 |
| 2023-12-31 | -$50.53M 10-K · filed 2025-03-20 |
| 2022-12-31 | $15.51M 10-K · filed 2024-03-20 |